http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-125272-C2

Outgoing Links

Predicate Object
filingDate 2020-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-125272-C2
titleOfInvention PRODUCT IN THE FORM OF GEL COMPOSITION "BENZIDAFLASIVERDINE" WITH PROLONGED ACTION FOR THE TREATMENT OF PERIODONTIC TISSUE DISEASES
abstract The invention relates to medicine, namely dentistry, and can be used for the conservative treatment of inflammatory and dystrophic-inflammatory diseases of periodontal tissues. The proposed agent contains as active ingredient benzydamine hydrochloride in the form of ground to a powdery tablet T-sept and additionally contains as active ingredient proteflazide in the composition of the gel base containing sodium alginate, nipagin and water for injection, in the appropriate ratio.
priorityDate 2020-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5102882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450984220

Total number of triples: 13.